Difficult-to-treat rheumatoid arthritis
Clinical trials for Difficult-to-treat rheumatoid arthritis explained in plain language.
Never miss a new study
Get alerted when new Difficult-to-treat rheumatoid arthritis trials appear
Sign up with your email to follow new studies for Difficult-to-treat rheumatoid arthritis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new biologic ease rheumatoid arthritis when standard drugs fail?
Disease control Recruiting nowThis phase 2 trial tests whether telitacicept, an experimental biologic given as a weekly injection, can improve symptoms in people with difficult-to-treat rheumatoid arthritis. Participants receive either telitacicept plus standard therapy or standard therapy alone for 24 weeks.…
Matched conditions: DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
10,000-Patient study aims to unlock best of both worlds for arthritis
Knowledge-focused Recruiting nowThis large observational study will follow 10,000 people with rheumatoid arthritis (RA) who are receiving a combination of Traditional Chinese Medicine (TCM) and standard Western medicine. Researchers will collect health data and biological samples over time to understand which t…
Matched conditions: DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
Sponsor: Dongyi He • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC